Linezolid is no better than vancomycin for treatment of nosocomial pneumonia - JAAPA
Links shared publicly online about this topic.
- 598total visits
Linezolid is no better than vancomycin for treatment of nosocomial pneumonia - JAAPA
View full resource at jaapa.com
Tags: Pneumonia, Antibiotic, Zyvox, Vancomycin
Most Recently Shared on January 7, 2011 at 3:56 pm By:
Linezolid is no better than vancomycin for treatment of nosocomial pneumonia: Clinical question: Is linezolid mo... http://bit.ly/i1polk
Linezolid has benefits in MRSA nosocomial pneumonia: study - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – For nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA), linezolid is more effective and better tolerated than the gold standard vancomycin, according to a randomized controlled trial. MRSA accounts for 10% to 40% of cases of...” View full resource at thedoctorschannel.com
Most Recently Shared on January 23, 2012 at 10:39 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
Linezolid or vancomycin to treat MRSA nosocomial pneumonia? - From Reuters Health/TDC http://t.co/0hVMXHbR #health
Linezolid bested vancomycin for treatment of nosocomial pneumonia due to MRSA
pediatricsupersite.com — “IDSA 48th Annual Meeting Linezolid had an end-of-study success rate that was more than 10% higher than vancomycin in patients with nosocomia” View full resource at pediatricsupersite.com
Most Recently Shared on November 1, 2010 at 4:08 pm By:
Pediatric SuperSite Health Site
#Linezolid bested #vancomycin for treatment of nosocomial pneumonia due to #MRSA: http://ow.ly/32C7Q
Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study
news-medical.net — “Results of a new international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant Staphylococcus aureus (MRSA) demonstrated that the antibiotic Zyvox® (linezolid) achieved a statistically significantly higher clinical success rate compared with vancomycin for the primary endpoint. The ZEPHyR (Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus) study was the largest ever conduct” View full resource at news-medical.net
Most Recently Shared on October 21, 2010 at 1:10 pm By:
Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study: Results of a new i... http://bit.ly/9veTO6
Advertisement
